SCOTTSDALE, Ariz., Feb. 15, 2011 /PRNewswire/ — Cayenne
Medical, Inc., a private sports medicine device company, announces
the launch of AperFix® II, its second generation soft tissue
repair device for multi-ligament repairs of the knee. The
announcement was made today at the 2011 American Academy of
Orthopaedic Surgeons (AAOS) Annual Meeting in San Diego, CA.
Key to AperFix II is the introduction of its new Cannulated
Tibial System, which provides surgeons with increased
ease-of-insertion and standardized positioning of the implant. For
anterior cruciate ligament (ACL) repair, the system allows for
rotation of the two tendons representing the anteromedial (AM) and
posterolateral (PL) bundles to more accurately match the
positioning of the native ACL bundles. Additionally, new
enhancements to the femoral device allow for easier graft insertion
and placement within the tunnel.
“The AperFix II System offers a simple and efficient technique
to obtain consistent circumferential graft compression, restoring
native knee kinematics,” said Kenneth Montgomery MD, orthopedic
surgeon, Tri-County Orthopaedic & Sports Medicine, Morristown,
NJ. “I believe this procedural enhancement will ensure the
integrity and strength of the reconstructed ligament, providing
patients with a more stable knee.”
The addition of the Cannulated Tibial System, along with
enhancements to the femoral device, serve to strengthen Cayenne
Medical’s innovative AperFix ligament reconstruction technology,
which utilizes a single tunnel, all-inside approach for attaching
the soft tissue graft at the aperture of the femoral and tibial
tunnels. This technique creates a shorter, stiffer and more
anatomic ligament repair.
“As the industry continues to lean in favor of soft tissue
ligament reconstruction, we have seen much success with our
flagship product AperFix and an increasing interest in its anatomic
repair through aperture graft fixation,” said J
‘/>”/>